Astrana Health, Inc. (NASDAQ:ASTH) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Shares of Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) have received an average rating of "Moderate Buy" from the nine brokerages that are currently covering the company, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $53.29.

A number of equities analysts have commented on ASTH shares. Stifel Nicolaus reduced their price target on shares of Astrana Health from $70.00 to $56.00 and set a "buy" rating on the stock in a research report on Thursday, February 20th. Bank of America decreased their price target on Astrana Health from $55.00 to $49.00 and set a "buy" rating on the stock in a research report on Tuesday, March 4th. Robert W. Baird cut their price objective on Astrana Health from $86.00 to $50.00 and set an "outperform" rating for the company in a research report on Monday, March 3rd. Barclays started coverage on Astrana Health in a research note on Tuesday, April 1st. They issued an "equal weight" rating and a $36.00 price objective on the stock. Finally, Truist Financial lowered their target price on Astrana Health from $50.00 to $46.00 and set a "buy" rating for the company in a research note on Tuesday, March 18th.

Astrana Health Price Performance

NASDAQ ASTH traded down $0.60 on Tuesday, reaching $25.75. The company's stock had a trading volume of 212,743 shares, compared to its average volume of 292,289. Astrana Health has a 52 week low of $23.12 and a 52 week high of $63.20. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. The firm has a market cap of $1.44 billion, a PE ratio of 19.81, a price-to-earnings-growth ratio of 1.37 and a beta of 0.85. The business has a 50-day moving average price of $28.81 and a 200 day moving average price of $32.51.

Astrana Health (NASDAQ:ASTH - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.09). Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The company had revenue of $620.39 million for the quarter, compared to analyst estimates of $628.11 million. During the same quarter in the prior year, the company earned $0.31 earnings per share. The business's revenue was up 53.4% compared to the same quarter last year. Sell-side analysts expect that Astrana Health will post 1.15 EPS for the current year.

Hedge Funds Weigh In On Astrana Health

Hedge funds and other institutional investors have recently bought and sold shares of the business. KBC Group NV lifted its stake in shares of Astrana Health by 108.4% in the 4th quarter. KBC Group NV now owns 2,530 shares of the company's stock valued at $80,000 after purchasing an additional 1,316 shares during the period. State of New Jersey Common Pension Fund D lifted its stake in Astrana Health by 25.4% in the fourth quarter. State of New Jersey Common Pension Fund D now owns 51,287 shares of the company's stock valued at $1,617,000 after buying an additional 10,389 shares during the period. Truist Financial Corp acquired a new position in Astrana Health in the fourth quarter valued at about $315,000. Handelsbanken Fonder AB boosted its holdings in Astrana Health by 4.7% during the fourth quarter. Handelsbanken Fonder AB now owns 8,900 shares of the company's stock worth $281,000 after buying an additional 400 shares during the last quarter. Finally, Hussman Strategic Advisors Inc. bought a new stake in shares of Astrana Health in the 4th quarter valued at about $1,986,000. 52.77% of the stock is owned by institutional investors.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.